Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02991898 · OUTCOME

Number of Participants With Grade II-IV aGVHD

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · Source last updated 2020-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Assessed weekly until day 100, then day 180, 360

What was measured

Probability of grade II-IV aGVHD

Groups in this outcome

Treg Infusion

The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treg Infusion3

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treg Infusion2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      3
    units
    Participants
description
Probability of grade II-IV aGVHD
groups
  1. description
    The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion
    id
    OG000
    title
    Treg Infusion
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Assessed weekly until day 100, then day 180, 360
title
Number of Participants With Grade II-IV aGVHD
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice